跳至主要内容
临床试验/NL-OMON22443
NL-OMON22443已完成不适用

The clinical effects of leukocyte removal filters, cellsavers and their combination on blood transfusion and organ damage during cardiac surgery.

Anesthesiology dpt University medical center Groningen0 个研究点目标入组 650 人开始时间: 待定最近更新:

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
650

研究概览

简要总结

/A

研究设计

研究类型
Interventional

入排标准

入选标准

  • In this randomized prospective unblinded multicenter study 600 adult patients scheduled for cardiac surgery will be included after informed consent.
  • The study is not blinded, because intraoperative cell saving cannot be concealed by the size and noise of the apparatus. Blockwise randomization will be employed to avoid imbalance. Numbered, sealed randomisation envelopes will be used. Randomization will be registered centrally. The randomization code will not be revealed to any of the participating investigators.

排除标准

  • Excluded are patients with known coagulation disorders except from the use of aspirin or low molecular weight heparin given at least 10 hours before surgery. Patients under 18 years or patients presenting for emergency operations are excluded.

研究者

发起方
Anesthesiology dpt University medical center Groningen

相似试验